GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test
Welcome to DNA Labs UAE, where we offer the GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test. This test helps in diagnosing and understanding the rare genetic disorder called Generalized epilepsy with febrile seizures plus type 3 (GEFS+3).
Test Components and Price
The GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test is priced at AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Method
The test utilizes NGS (Next-generation sequencing) technology, which allows for the analysis of multiple genes simultaneously.
Test Type
The GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test falls under the category of Neurological Disorders.
Doctor and Test Department
This test is conducted by a Neurologist in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with GEFS+3.
Test Details
The GABRG2 gene is associated with the rare genetic disorder called Generalized epilepsy with febrile seizures plus type 3 (GEFS+3). This disorder is characterized by recurrent febrile seizures in childhood, followed by a range of seizure types that can continue into adulthood. NGS technology allows for the sequencing of the GABRG2 gene to identify any mutations or variations that may be contributing to the disorder. Genetic testing for GEFS+3 can confirm a diagnosis, provide information about the risk of passing the disorder to future generations, guide treatment decisions, and identify at-risk family members who may benefit from genetic counseling.
| Test Name | GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 |
| Test Details | The GABRG2 gene is associated with a rare genetic disorder called Generalized epilepsy with febrile seizures plus type 3 (GEFS+3). This disorder is characterized by recurrent febrile seizures in childhood, followed by a range of seizure types that can continue into adulthood. NGS (Next-generation sequencing) is a genetic testing method that allows for the analysis of multiple genes simultaneously, making it a powerful tool for identifying genetic mutations associated with various disorders. In the case of GEFS+3, NGS can be used to sequence the GABRG2 gene and identify any mutations or variations that may be contributing to the disorder. Genetic testing for GEFS+3 can help to confirm a diagnosis, provide information about the risk of passing the disorder on to future generations, and guide treatment decisions. It can also help to identify family members who may be at risk for the disorder and provide them with appropriate genetic counseling. |
